Clinical Trial Update: A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

View source ↗

Summary

A clinical study evaluating HyQvia (subcutaneous immunoglobulin with hyaluronidase) in adults with chronic inflammatory demyelinating polyradiculoneuropathy (CI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyradiculoneuropathy

Drugs mentioned

• HYQVIA (immunoglobulin G (IgG) with recombinant human hyaluronidase)

Snippet

Sponsor: Takeda | Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | Status: RECRUITING